Search Results 221-230 of 17385 for Bronchodilators

  1. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  2. Exercise-induced asthma - Symptoms & causes - Mayo Clinic

    Exercise-induced asthma happens when the airways narrow or squeeze during or after physical activity. It causes shortness of breath, wheezing, coughing and ...

  3. https://www.mayoclinic.org/spanish_organization_concepts.xml

  4. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Intermittent use of bronchodilators or local steroid injections;; Hypothyroidism stable on hormone replacement;; Diabetes stable with current management ...

  5. Racepinephrine (inhalation route) - Side effects & dosage - Mayo Clinic

    In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other ...

  6. Home-based Pulmonary Rehabilitation and Health Coaching to Treat Bronchiectasis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Evaluate Lung Function in Subjects with Idiopathic Pulmonary Fibrosis (IPF) After Taking BI 1015550 for 12 Weeks - Mayo Clinic

    Relevant airways obstruction (pre-bronchodilator FEV1/FVC < 0.7) at Visit 1. In the opinion of the Investigator, other clinically significant pulmonary ...

  8. Publications - Remzi Bag, M.D. - Mayo Clinic

    2003 May; 9(3):193-8. View PubMed; Bag R, Bandi V, Fromm RE Jr, Guntupalli KK. The effect of heliox-driven bronchodilator aerosol therapy on pulmonary function ...

  9. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  10. Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection (Tailwind) - Mayo Clinic

    ... bronchodilator) or during the Screening Period. Have, at the Baseline Visit, stable lung function, as determined by the Investigator, provided that the FEV1 ...